Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Colchicine for ventricular and supraventricular arrhythmias in patients with implantable cardioverter-defibrillators
IRCT20120520009801N13Phase 3Completed
- Sponsor
- Mashhad University of Medical Sciences
- Start
- Jul 2024
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, triple-blind trial in ventricular arrhythmia (VA) and Supraventricular arrhythmia (SVA) comparing Colchicine with Placebo (2 arms). Primary endpoints: Frequency of ventricular arrhythmias and Frequency of supraventricular arrhythmias. Started Jul 2024; status: completed.
02
Drugs
colchicine
03
Conditions
ventricular arrhythmia (VA)Supraventricular arrhythmia (SVA)
Beyond the preview
Go deeper on IRCT20120520009801N13.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20120520009801N13.